| Pharmaceutical active ingredients: |
| AmlodipineHydrochlorothiazideValsartan |
| Available forms, composition and doses of Exforge HCT: |
| Tablets; Oral; Amlodipine 10 mg; Hydrochlorothiazide 12.5 mg; Valsartan 160 mgTablets; Oral; Amlodipine 10 mg; Hydrochlorothiazide 25 mg; Valsartan 160 mgTablets; Oral; Amlodipine 10 mg; Hydrochlorothiazide 25 mg; Valsartan 320 mgTablets; Oral; Amlodipine 5 mg; Hydrochlorothiazide 12.5 mg; Valsartan 160 mgTablets; Oral; Amlodipine 5 mg; Hydrochlorothiazide 25 mg; Valsartan 160 mg |
| Exforge HCT medical category: |
| Human:Angiotensin II antagonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C09DX01 - Valsartan, amlodipine and hydrochlorothiazide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisZuellig Pharma |
| Related documents and information about Exforge HCT: |
| Exforge prescribing information (PDF)Exforge HCT prescribing information (PDF) |